PetIQ Inc Class A PETQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PETQ is a good fit for your portfolio.
News
-
PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
-
PetIQ, Inc. Celebrates Expansion of Minties® Dental Treats Brand With Launch of New Dental Chew for Large-Sized Dogs
-
PetIQ, Inc. Kicks Off Flea & Tick Season With NextStar® Campaign Introducing New Pet Parent Education and Veterinary Support Resources
-
PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
PetIQ, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
Trading Information
- Previous Close Price
- $16.49
- Day Range
- $16.42–16.73
- 52-Week Range
- $11.26–22.85
- Bid/Ask
- $16.75 / $16.86
- Market Cap
- $493.25 Mil
- Volume/Avg
- 78,670 / 312,758
Key Statistics
- Price/Earnings (Normalized)
- 13.78
- Price/Sales
- 0.44
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
PetIQ Inc is a manufacturer and distributor of health and wellness products for dogs and cats. The company offers veterinarian-grade pet Rx medications, OTC flea and tick preventatives, vitamins treats, nutritional supplements, and hygiene products. The group operates in two segments namely the Products and Services segments. It also provides third-party products to retailers which for a long time are available for veterinary clinics only. Its proprietary brands include PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, TruProfen, Betsy Farms, PetAction, Minties, Vera and Delightibles. The company generates maximum revenue from Products segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,933
- Website
- https://www.petiq.com
Comparables
Valuation
|
Metric
|
PETQ
|
SCLX
|
BTCA
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.78 | — | — |
Price/Book Value | 2.18 | — | — |
Price/Sales | 0.44 | 2.65 | — |
Price/Cash Flow | 7.63 | — | — |
Price/Earnings
PETQ
SCLX
BTCA
Financial Strength
|
Metric
|
PETQ
|
SCLX
|
BTCA
|
|---|---|---|---|
Quick Ratio | 1.37 | 0.15 | 1.06 |
Current Ratio | 2.27 | 0.19 | 1.95 |
Interest Coverage | 1.07 | −106.04 | — |
Quick Ratio
PETQ
SCLX
BTCA
Profitability
|
Metric
|
PETQ
|
SCLX
|
BTCA
|
|---|---|---|---|
Return on Assets (Normalized) | 4.26% | −106.47% | 9.07% |
Return on Equity (Normalized) | 16.31% | — | 13.08% |
Return on Invested Capital (Normalized) | 9.21% | −1,960.39% | 10.34% |
Return on Assets
PETQ
SCLX
BTCA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Xpylblkxdh | Fpn | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Kkxlwnktbh | Qrqlff | $68.4 Bil | |
HLN
| Haleon PLC ADR | Mbjjlsxvp | Pqxp | $37.0 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Gfjqtxdx | Ldp | $14.5 Bil | |
VTRS
| Viatris Inc | Hrbgqmgvw | Cvcq | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kpbcvmyyx | Vmq | $12.0 Bil | |
CTLT
| Catalent Inc | Yqlczxj | Bgqdf | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Dzxrhrn | Lnnc | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Bbgmqmdf | Gglwl | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Phgvjlnj | Pcmyfn | $3.5 Bil |